ISTA Pharmaceuticals is the fastest growing US branded ophthalmic pharmaceutical company, having recently become the fifth largest in the US market. The company’s products and product candidates addressing the $5.1 billion US prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy and dry eye. ISTA Pharmaceuticals also is developing a strong product pipeline to fuel future growth and market share, continuing its growth to become the leading niche ophthalmic pharmaceutical company in the US.

PleaseReview provides a secure, collaborative, browser-based environment to manage the document review and authoring process. It enables simultaneous authoring and review of Microsoft Word and PowerPoint documents, PDFs and images. Users virtually discuss and agree on documents with each other, paragraph by paragraph, taking advantage of simple ‘point and click’ review tools. Reviews may be synchronous or asynchronous. The document author or manager has full control of the review and can monitor the users’ progress. All changes and comments are automatically saved in an audit trail.

“As a pharmaceutical company we are regulated by the FDA and have to submit extensive documentation as part of the regulatory process,” says Keith Bereskin, director of information technology at ISTA. “Naturally it is important that this documentation is of the highest quality and that means it needs to be extensively reviewed. After an extensive evaluation by our regulatory operations group, we concluded that PleaseReview would deliver an efficient document review solution by reducing review cycles.”

PleaseTech’s CEO David Cornwell says: “ISTA Pharmaceuticals is a leader in the ophthalmic pharmaceutical area and we are delighted that they have selected PleaseReview to be part of their regulatory document review process.”